Chalice Brands Ltd.
Chalice Brands Ltd. CHALF Peers
See (CHALF) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CHALF | $0.38 | +3799900.00% | 441.8B | -4.75 | -$0.08 | N/A |
| STMH | $0.10 | +99900.00% | 125B | -0.05 | -$1.89 | N/A |
| MKGAF | $134.75 | +3.81% | 58.6B | 18.36 | $7.34 | +1.64% |
| THCBF | $0.02 | +2350.00% | 58B | -2.45 | -$0.01 | N/A |
| MKKGY | $26.40 | +0.57% | 57.2B | 17.96 | $1.47 | +2.16% |
| TKPHF | $32.13 | N/A | 50.6B | 69.85 | $0.46 | +4.14% |
| HLNCF | $5.50 | -2.14% | 49.6B | 26.19 | $0.21 | +1.97% |
| KHRNF | $0.01 | +79900.00% | 41.6B | -0.80 | -$0.01 | N/A |
| IPSEY | $29.60 | +2.28% | 39.2B | 24.26 | $1.22 | +1.07% |
| EVRRF | $0.07 | +2780.00% | 25.5B | -2.40 | -$0.03 | N/A |
Stock Comparison
CHALF vs STMH Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, STMH has a market cap of 125B. Regarding current trading prices, CHALF is priced at $0.38, while STMH trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas STMH's P/E ratio is -0.05. In terms of profitability, CHALF's ROE is +0.00%, compared to STMH's ROE of -2.75%. Regarding short-term risk, CHALF is more volatile compared to STMH. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs MKGAF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, MKGAF has a market cap of 58.6B. Regarding current trading prices, CHALF is priced at $0.38, while MKGAF trades at $134.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas MKGAF's P/E ratio is 18.36. In terms of profitability, CHALF's ROE is +0.00%, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, CHALF is more volatile compared to MKGAF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs THCBF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, THCBF has a market cap of 58B. Regarding current trading prices, CHALF is priced at $0.38, while THCBF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas THCBF's P/E ratio is -2.45. In terms of profitability, CHALF's ROE is +0.00%, compared to THCBF's ROE of +0.00%. Regarding short-term risk, CHALF is more volatile compared to THCBF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs MKKGY Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, MKKGY has a market cap of 57.2B. Regarding current trading prices, CHALF is priced at $0.38, while MKKGY trades at $26.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas MKKGY's P/E ratio is 17.96. In terms of profitability, CHALF's ROE is +0.00%, compared to MKKGY's ROE of +0.10%. Regarding short-term risk, CHALF is more volatile compared to MKKGY. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs TKPHF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, TKPHF has a market cap of 50.6B. Regarding current trading prices, CHALF is priced at $0.38, while TKPHF trades at $32.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas TKPHF's P/E ratio is 69.85. In terms of profitability, CHALF's ROE is +0.00%, compared to TKPHF's ROE of +0.03%. Regarding short-term risk, CHALF is more volatile compared to TKPHF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs HLNCF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, HLNCF has a market cap of 49.6B. Regarding current trading prices, CHALF is priced at $0.38, while HLNCF trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas HLNCF's P/E ratio is 26.19. In terms of profitability, CHALF's ROE is +0.00%, compared to HLNCF's ROE of +0.09%. Regarding short-term risk, CHALF is more volatile compared to HLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs KHRNF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, KHRNF has a market cap of 41.6B. Regarding current trading prices, CHALF is priced at $0.38, while KHRNF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas KHRNF's P/E ratio is -0.80. In terms of profitability, CHALF's ROE is +0.00%, compared to KHRNF's ROE of -0.69%. Regarding short-term risk, CHALF is more volatile compared to KHRNF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs IPSEY Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, IPSEY has a market cap of 39.2B. Regarding current trading prices, CHALF is priced at $0.38, while IPSEY trades at $29.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas IPSEY's P/E ratio is 24.26. In terms of profitability, CHALF's ROE is +0.00%, compared to IPSEY's ROE of +0.17%. Regarding short-term risk, CHALF is more volatile compared to IPSEY. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs EVRRF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, EVRRF has a market cap of 25.5B. Regarding current trading prices, CHALF is priced at $0.38, while EVRRF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas EVRRF's P/E ratio is -2.40. In terms of profitability, CHALF's ROE is +0.00%, compared to EVRRF's ROE of +2.97%. Regarding short-term risk, CHALF is more volatile compared to EVRRF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs SDZNY Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, SDZNY has a market cap of 21.8B. Regarding current trading prices, CHALF is priced at $0.38, while SDZNY trades at $50.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas SDZNY's P/E ratio is -2535.00. In terms of profitability, CHALF's ROE is +0.00%, compared to SDZNY's ROE of +0.00%. Regarding short-term risk, CHALF is more volatile compared to SDZNY. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs TEVJF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, TEVJF has a market cap of 20.4B. Regarding current trading prices, CHALF is priced at $0.38, while TEVJF trades at $17.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas TEVJF's P/E ratio is -15.48. In terms of profitability, CHALF's ROE is +0.00%, compared to TEVJF's ROE of -0.21%. Regarding short-term risk, CHALF is more volatile compared to TEVJF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs SRUTF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, SRUTF has a market cap of 19.5B. Regarding current trading prices, CHALF is priced at $0.38, while SRUTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas SRUTF's P/E ratio is -0.09. In terms of profitability, CHALF's ROE is +0.00%, compared to SRUTF's ROE of +18.75%. Regarding short-term risk, CHALF is more volatile compared to SRUTF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs ESALY Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, CHALF is priced at $0.38, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas ESALY's P/E ratio is 20.54. In terms of profitability, CHALF's ROE is +0.00%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, CHALF is more volatile compared to ESALY. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs SGIOY Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, SGIOY has a market cap of 14.1B. Regarding current trading prices, CHALF is priced at $0.38, while SGIOY trades at $8.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas SGIOY's P/E ratio is 11.83. In terms of profitability, CHALF's ROE is +0.00%, compared to SGIOY's ROE of +0.08%. Regarding short-term risk, CHALF is more volatile compared to SGIOY. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs SGIOF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, SGIOF has a market cap of 12.9B. Regarding current trading prices, CHALF is priced at $0.38, while SGIOF trades at $15.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas SGIOF's P/E ratio is 10.86. In terms of profitability, CHALF's ROE is +0.00%, compared to SGIOF's ROE of +0.08%. Regarding short-term risk, CHALF is more volatile compared to SGIOF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs IPSEF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, IPSEF has a market cap of 10.4B. Regarding current trading prices, CHALF is priced at $0.38, while IPSEF trades at $125.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas IPSEF's P/E ratio is 26.23. In terms of profitability, CHALF's ROE is +0.00%, compared to IPSEF's ROE of +0.14%. Regarding short-term risk, CHALF is more volatile compared to IPSEF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs RDDTF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, RDDTF has a market cap of 9.7B. Regarding current trading prices, CHALF is priced at $0.38, while RDDTF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas RDDTF's P/E ratio is -0.50. In terms of profitability, CHALF's ROE is +0.00%, compared to RDDTF's ROE of +0.00%. Regarding short-term risk, CHALF is more volatile compared to RDDTF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs BIOVF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, BIOVF has a market cap of 9.3B. Regarding current trading prices, CHALF is priced at $0.38, while BIOVF trades at $27.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas BIOVF's P/E ratio is 22.50. In terms of profitability, CHALF's ROE is +0.00%, compared to BIOVF's ROE of +0.10%. Regarding short-term risk, CHALF is more volatile compared to BIOVF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs SFOSF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, SFOSF has a market cap of 8.7B. Regarding current trading prices, CHALF is priced at $0.38, while SFOSF trades at $2.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas SFOSF's P/E ratio is 13.40. In terms of profitability, CHALF's ROE is +0.00%, compared to SFOSF's ROE of +0.06%. Regarding short-term risk, CHALF is more volatile compared to SFOSF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs NOBDF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, NOBDF has a market cap of 8.5B. Regarding current trading prices, CHALF is priced at $0.38, while NOBDF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas NOBDF's P/E ratio is N/A. In terms of profitability, CHALF's ROE is +0.00%, compared to NOBDF's ROE of -0.54%. Regarding short-term risk, CHALF is more volatile compared to NOBDF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs ESAIY Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, ESAIY has a market cap of 8B. Regarding current trading prices, CHALF is priced at $0.38, while ESAIY trades at $7.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas ESAIY's P/E ratio is 25.36. In terms of profitability, CHALF's ROE is +0.00%, compared to ESAIY's ROE of +0.03%. Regarding short-term risk, CHALF is more volatile compared to ESAIY. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs ESALF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, ESALF has a market cap of 7.8B. Regarding current trading prices, CHALF is priced at $0.38, while ESALF trades at $27.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas ESALF's P/E ratio is 24.12. In terms of profitability, CHALF's ROE is +0.00%, compared to ESALF's ROE of +0.03%. Regarding short-term risk, CHALF is more volatile compared to ESALF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs GZPHF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, GZPHF has a market cap of 6.3B. Regarding current trading prices, CHALF is priced at $0.38, while GZPHF trades at $2.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas GZPHF's P/E ratio is 10.61. In terms of profitability, CHALF's ROE is +0.00%, compared to GZPHF's ROE of +0.07%. Regarding short-term risk, CHALF is more volatile compared to GZPHF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs HKMPY Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, HKMPY has a market cap of 6.3B. Regarding current trading prices, CHALF is priced at $0.38, while HKMPY trades at $56.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas HKMPY's P/E ratio is 17.67. In terms of profitability, CHALF's ROE is +0.00%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, CHALF is more volatile compared to HKMPY. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs HKMPF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, HKMPF has a market cap of 5.9B. Regarding current trading prices, CHALF is priced at $0.38, while HKMPF trades at $26.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas HKMPF's P/E ratio is 16.50. In terms of profitability, CHALF's ROE is +0.00%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, CHALF is more volatile compared to HKMPF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs HLUBF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, HLUBF has a market cap of 5.2B. Regarding current trading prices, CHALF is priced at $0.38, while HLUBF trades at $5.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas HLUBF's P/E ratio is 11.31. In terms of profitability, CHALF's ROE is +0.00%, compared to HLUBF's ROE of +0.13%. Regarding short-term risk, CHALF is more volatile compared to HLUBF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs HLBBF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, HLBBF has a market cap of 4.8B. Regarding current trading prices, CHALF is priced at $0.38, while HLBBF trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas HLBBF's P/E ratio is 12.71. In terms of profitability, CHALF's ROE is +0.00%, compared to HLBBF's ROE of +0.13%. Regarding short-term risk, CHALF is more volatile compared to HLBBF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs LVZPF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, LVZPF has a market cap of 4.2B. Regarding current trading prices, CHALF is priced at $0.38, while LVZPF trades at $3.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas LVZPF's P/E ratio is 12.37. In terms of profitability, CHALF's ROE is +0.00%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, CHALF is more volatile compared to LVZPF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs APNHF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, APNHF has a market cap of 4.1B. Regarding current trading prices, CHALF is priced at $0.38, while APNHF trades at $9.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas APNHF's P/E ratio is 15.08. In terms of profitability, CHALF's ROE is +0.00%, compared to APNHF's ROE of +0.04%. Regarding short-term risk, CHALF is more volatile compared to APNHF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs APNHY Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, APNHY has a market cap of 3B. Regarding current trading prices, CHALF is priced at $0.38, while APNHY trades at $6.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas APNHY's P/E ratio is 12.21. In terms of profitability, CHALF's ROE is +0.00%, compared to APNHY's ROE of +0.05%. Regarding short-term risk, CHALF is more volatile compared to APNHY. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs INVVY Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, CHALF is priced at $0.38, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas INVVY's P/E ratio is -62.42. In terms of profitability, CHALF's ROE is +0.00%, compared to INVVY's ROE of -0.01%. Regarding short-term risk, CHALF is more volatile compared to INVVY. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs IZQVF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, CHALF is priced at $0.38, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, CHALF's ROE is +0.00%, compared to IZQVF's ROE of -0.01%. Regarding short-term risk, CHALF is more volatile compared to IZQVF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs HYPMY Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, HYPMY has a market cap of 2.9B. Regarding current trading prices, CHALF is priced at $0.38, while HYPMY trades at $4.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas HYPMY's P/E ratio is 19.78. In terms of profitability, CHALF's ROE is +0.00%, compared to HYPMY's ROE of +0.07%. Regarding short-term risk, CHALF is more volatile compared to HYPMY. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs WIBFF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, WIBFF has a market cap of 2.8B. Regarding current trading prices, CHALF is priced at $0.38, while WIBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas WIBFF's P/E ratio is -0.01. In terms of profitability, CHALF's ROE is +0.00%, compared to WIBFF's ROE of +0.00%. Regarding short-term risk, CHALF is more volatile compared to WIBFF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs ULIHF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, ULIHF has a market cap of 2.5B. Regarding current trading prices, CHALF is priced at $0.38, while ULIHF trades at $1.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas ULIHF's P/E ratio is 7.00. In terms of profitability, CHALF's ROE is +0.00%, compared to ULIHF's ROE of +0.21%. Regarding short-term risk, CHALF is more volatile compared to ULIHF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs HMDCF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, HMDCF has a market cap of 2.5B. Regarding current trading prices, CHALF is priced at $0.38, while HMDCF trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas HMDCF's P/E ratio is -58.00. In terms of profitability, CHALF's ROE is +0.00%, compared to HMDCF's ROE of -0.01%. Regarding short-term risk, CHALF is more volatile compared to HMDCF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs SHEZF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, SHEZF has a market cap of 2.5B. Regarding current trading prices, CHALF is priced at $0.38, while SHEZF trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas SHEZF's P/E ratio is -36.03. In terms of profitability, CHALF's ROE is +0.00%, compared to SHEZF's ROE of +0.05%. Regarding short-term risk, CHALF is more volatile compared to SHEZF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs HTSUF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, HTSUF has a market cap of 2.4B. Regarding current trading prices, CHALF is priced at $0.38, while HTSUF trades at $33.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas HTSUF's P/E ratio is 16.10. In terms of profitability, CHALF's ROE is +0.00%, compared to HTSUF's ROE of +0.05%. Regarding short-term risk, CHALF is more volatile compared to HTSUF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs DNPUF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, DNPUF has a market cap of 2.3B. Regarding current trading prices, CHALF is priced at $0.38, while DNPUF trades at $5.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas DNPUF's P/E ratio is 13.81. In terms of profitability, CHALF's ROE is +0.00%, compared to DNPUF's ROE of -1.05%. Regarding short-term risk, CHALF is more volatile compared to DNPUF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs CHSYF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, CHSYF has a market cap of 2.2B. Regarding current trading prices, CHALF is priced at $0.38, while CHSYF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas CHSYF's P/E ratio is 6.65. In terms of profitability, CHALF's ROE is +0.00%, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, CHALF is more volatile compared to CHSYF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs TSMRF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, TSMRF has a market cap of 2.1B. Regarding current trading prices, CHALF is priced at $0.38, while TSMRF trades at $28.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas TSMRF's P/E ratio is 13.03. In terms of profitability, CHALF's ROE is +0.00%, compared to TSMRF's ROE of +0.07%. Regarding short-term risk, CHALF is more volatile compared to TSMRF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs DMPHF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, DMPHF has a market cap of 2.1B. Regarding current trading prices, CHALF is priced at $0.38, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas DMPHF's P/E ratio is 18.15. In terms of profitability, CHALF's ROE is +0.00%, compared to DMPHF's ROE of +0.20%. Regarding short-term risk, CHALF is more volatile compared to DMPHF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs LBTSF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, LBTSF has a market cap of 2.1B. Regarding current trading prices, CHALF is priced at $0.38, while LBTSF trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas LBTSF's P/E ratio is 162.50. In terms of profitability, CHALF's ROE is +0.00%, compared to LBTSF's ROE of +0.01%. Regarding short-term risk, CHALF is more volatile compared to LBTSF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs LJUIF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, LJUIF has a market cap of 2.1B. Regarding current trading prices, CHALF is priced at $0.38, while LJUIF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas LJUIF's P/E ratio is 13.97. In terms of profitability, CHALF's ROE is +0.00%, compared to LJUIF's ROE of +0.19%. Regarding short-term risk, CHALF is more volatile compared to LJUIF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs NPNKF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, NPNKF has a market cap of 1.7B. Regarding current trading prices, CHALF is priced at $0.38, while NPNKF trades at $25.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas NPNKF's P/E ratio is 7.55. In terms of profitability, CHALF's ROE is +0.00%, compared to NPNKF's ROE of +0.09%. Regarding short-term risk, CHALF is more volatile compared to NPNKF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs CHIZF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, CHIZF has a market cap of 1.7B. Regarding current trading prices, CHALF is priced at $0.38, while CHIZF trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas CHIZF's P/E ratio is 16.80. In terms of profitability, CHALF's ROE is +0.00%, compared to CHIZF's ROE of +0.04%. Regarding short-term risk, CHALF is more volatile compared to CHIZF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs YIHCF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, YIHCF has a market cap of 1.7B. Regarding current trading prices, CHALF is priced at $0.38, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, CHALF's ROE is +0.00%, compared to YIHCF's ROE of +0.19%. Regarding short-term risk, CHALF is more volatile compared to YIHCF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs EVOTF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, EVOTF has a market cap of 1.6B. Regarding current trading prices, CHALF is priced at $0.38, while EVOTF trades at $9.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas EVOTF's P/E ratio is -8.38. In terms of profitability, CHALF's ROE is +0.00%, compared to EVOTF's ROE of -0.22%. Regarding short-term risk, CHALF is more volatile compared to EVOTF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs SMDPY Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, SMDPY has a market cap of 1.6B. Regarding current trading prices, CHALF is priced at $0.38, while SMDPY trades at $4.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas SMDPY's P/E ratio is 10.00. In terms of profitability, CHALF's ROE is +0.00%, compared to SMDPY's ROE of -1.44%. Regarding short-term risk, CHALF is more volatile compared to SMDPY. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs MITPF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, CHALF is priced at $0.38, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas MITPF's P/E ratio is -10.81. In terms of profitability, CHALF's ROE is +0.00%, compared to MITPF's ROE of +4.92%. Regarding short-term risk, CHALF is more volatile compared to MITPF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs NPPNY Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, NPPNY has a market cap of 1.6B. Regarding current trading prices, CHALF is priced at $0.38, while NPPNY trades at $5.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas NPPNY's P/E ratio is 6.89. In terms of profitability, CHALF's ROE is +0.00%, compared to NPPNY's ROE of +0.09%. Regarding short-term risk, CHALF is more volatile compared to NPPNY. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs KARBF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, CHALF is priced at $0.38, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas KARBF's P/E ratio is 262.50. In terms of profitability, CHALF's ROE is +0.00%, compared to KARBF's ROE of N/A. Regarding short-term risk, CHALF is more volatile compared to KARBF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs ARSUF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, ARSUF has a market cap of 1.5B. Regarding current trading prices, CHALF is priced at $0.38, while ARSUF trades at $20.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas ARSUF's P/E ratio is 18.78. In terms of profitability, CHALF's ROE is +0.00%, compared to ARSUF's ROE of +0.16%. Regarding short-term risk, CHALF is more volatile compared to ARSUF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs GTBIF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, GTBIF has a market cap of 1.2B. Regarding current trading prices, CHALF is priced at $0.38, while GTBIF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas GTBIF's P/E ratio is 25.00. In terms of profitability, CHALF's ROE is +0.00%, compared to GTBIF's ROE of +0.03%. Regarding short-term risk, CHALF is more volatile compared to GTBIF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs KSPHF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, KSPHF has a market cap of 1.2B. Regarding current trading prices, CHALF is priced at $0.38, while KSPHF trades at $27.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas KSPHF's P/E ratio is 14.28. In terms of profitability, CHALF's ROE is +0.00%, compared to KSPHF's ROE of +0.05%. Regarding short-term risk, CHALF is more volatile compared to KSPHF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs CASBF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, CASBF has a market cap of 1.2B. Regarding current trading prices, CHALF is priced at $0.38, while CASBF trades at $3.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas CASBF's P/E ratio is -17.81. In terms of profitability, CHALF's ROE is +0.00%, compared to CASBF's ROE of -0.14%. Regarding short-term risk, CHALF is more volatile compared to CASBF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs SWGHF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, SWGHF has a market cap of 1.1B. Regarding current trading prices, CHALF is priced at $0.38, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas SWGHF's P/E ratio is 15.57. In terms of profitability, CHALF's ROE is +0.00%, compared to SWGHF's ROE of +0.10%. Regarding short-term risk, CHALF is more volatile compared to SWGHF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs GNMLF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, GNMLF has a market cap of 1.1B. Regarding current trading prices, CHALF is priced at $0.38, while GNMLF trades at $1.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas GNMLF's P/E ratio is 10.36. In terms of profitability, CHALF's ROE is +0.00%, compared to GNMLF's ROE of +0.12%. Regarding short-term risk, CHALF is more volatile compared to GNMLF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs SHPHF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, SHPHF has a market cap of 1.1B. Regarding current trading prices, CHALF is priced at $0.38, while SHPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas SHPHF's P/E ratio is -4.06. In terms of profitability, CHALF's ROE is +0.00%, compared to SHPHF's ROE of -0.01%. Regarding short-term risk, CHALF is more volatile compared to SHPHF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs KKPCF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, KKPCF has a market cap of 1B. Regarding current trading prices, CHALF is priced at $0.38, while KKPCF trades at $26.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas KKPCF's P/E ratio is 10.46. In terms of profitability, CHALF's ROE is +0.00%, compared to KKPCF's ROE of +0.04%. Regarding short-term risk, CHALF is more volatile compared to KKPCF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs BIOGY Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, BIOGY has a market cap of 884.8M. Regarding current trading prices, CHALF is priced at $0.38, while BIOGY trades at $8.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas BIOGY's P/E ratio is 28.07. In terms of profitability, CHALF's ROE is +0.00%, compared to BIOGY's ROE of +0.18%. Regarding short-term risk, CHALF is more volatile compared to BIOGY. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs NRXCF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, NRXCF has a market cap of 839.1M. Regarding current trading prices, CHALF is priced at $0.38, while NRXCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas NRXCF's P/E ratio is -0.22. In terms of profitability, CHALF's ROE is +0.00%, compared to NRXCF's ROE of +2.32%. Regarding short-term risk, CHALF is more volatile compared to NRXCF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs TWAPF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, TWAPF has a market cap of 828.5M. Regarding current trading prices, CHALF is priced at $0.38, while TWAPF trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas TWAPF's P/E ratio is 6.30. In terms of profitability, CHALF's ROE is +0.00%, compared to TWAPF's ROE of +0.09%. Regarding short-term risk, CHALF is more volatile compared to TWAPF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs CSWYF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, CSWYF has a market cap of 815.8M. Regarding current trading prices, CHALF is priced at $0.38, while CSWYF trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas CSWYF's P/E ratio is 5.14. In terms of profitability, CHALF's ROE is +0.00%, compared to CSWYF's ROE of +0.07%. Regarding short-term risk, CHALF is more volatile compared to CSWYF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs TCNNF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, TCNNF has a market cap of 777.7M. Regarding current trading prices, CHALF is priced at $0.38, while TCNNF trades at $4.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas TCNNF's P/E ratio is -5.09. In terms of profitability, CHALF's ROE is +0.00%, compared to TCNNF's ROE of -0.13%. Regarding short-term risk, CHALF is more volatile compared to TCNNF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs AGYTF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, AGYTF has a market cap of 757.9M. Regarding current trading prices, CHALF is priced at $0.38, while AGYTF trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas AGYTF's P/E ratio is -15.90. In terms of profitability, CHALF's ROE is +0.00%, compared to AGYTF's ROE of -2.67%. Regarding short-term risk, CHALF is more volatile compared to AGYTF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs TRXPF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, TRXPF has a market cap of 690.7M. Regarding current trading prices, CHALF is priced at $0.38, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, CHALF's ROE is +0.00%, compared to TRXPF's ROE of +0.04%. Regarding short-term risk, CHALF is more volatile compared to TRXPF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs ABSCF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, ABSCF has a market cap of 682.7M. Regarding current trading prices, CHALF is priced at $0.38, while ABSCF trades at $11.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas ABSCF's P/E ratio is -67.65. In terms of profitability, CHALF's ROE is +0.00%, compared to ABSCF's ROE of +0.26%. Regarding short-term risk, CHALF is more volatile compared to ABSCF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs SWDCF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, SWDCF has a market cap of 679.3M. Regarding current trading prices, CHALF is priced at $0.38, while SWDCF trades at $4.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas SWDCF's P/E ratio is 70.83. In terms of profitability, CHALF's ROE is +0.00%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, CHALF is more volatile compared to SWDCF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs NIKA Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, NIKA has a market cap of 667.1M. Regarding current trading prices, CHALF is priced at $0.38, while NIKA trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas NIKA's P/E ratio is N/A. In terms of profitability, CHALF's ROE is +0.00%, compared to NIKA's ROE of +0.39%. Regarding short-term risk, CHALF is more volatile compared to NIKA. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs LVTTF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, LVTTF has a market cap of 658.1M. Regarding current trading prices, CHALF is priced at $0.38, while LVTTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas LVTTF's P/E ratio is -0.02. In terms of profitability, CHALF's ROE is +0.00%, compared to LVTTF's ROE of +0.00%. Regarding short-term risk, CHALF is more volatile compared to LVTTF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs CURLF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, CURLF has a market cap of 628.6M. Regarding current trading prices, CHALF is priced at $0.38, while CURLF trades at $0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas CURLF's P/E ratio is -2.52. In terms of profitability, CHALF's ROE is +0.00%, compared to CURLF's ROE of -0.25%. Regarding short-term risk, CHALF is more volatile compared to CURLF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs BOIRF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, BOIRF has a market cap of 622.4M. Regarding current trading prices, CHALF is priced at $0.38, while BOIRF trades at $35.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas BOIRF's P/E ratio is 25.25. In terms of profitability, CHALF's ROE is +0.00%, compared to BOIRF's ROE of +0.06%. Regarding short-term risk, CHALF is more volatile compared to BOIRF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs TRSSF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, CHALF is priced at $0.38, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, CHALF's ROE is +0.00%, compared to TRSSF's ROE of -0.32%. Regarding short-term risk, CHALF is more volatile compared to TRSSF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs ELTP Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, ELTP has a market cap of 573.7M. Regarding current trading prices, CHALF is priced at $0.38, while ELTP trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas ELTP's P/E ratio is -26.85. In terms of profitability, CHALF's ROE is +0.00%, compared to ELTP's ROE of -0.36%. Regarding short-term risk, CHALF is more volatile compared to ELTP. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs MNFSF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, MNFSF has a market cap of 566M. Regarding current trading prices, CHALF is priced at $0.38, while MNFSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas MNFSF's P/E ratio is -0.08. In terms of profitability, CHALF's ROE is +0.00%, compared to MNFSF's ROE of +16.59%. Regarding short-term risk, CHALF is more volatile compared to MNFSF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs SGFEF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, SGFEF has a market cap of 536.5M. Regarding current trading prices, CHALF is priced at $0.38, while SGFEF trades at $102.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas SGFEF's P/E ratio is 22.98. In terms of profitability, CHALF's ROE is +0.00%, compared to SGFEF's ROE of +0.11%. Regarding short-term risk, CHALF is more volatile compared to SGFEF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs CCHWF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, CHALF is priced at $0.38, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, CHALF's ROE is +0.00%, compared to CCHWF's ROE of -7.05%. Regarding short-term risk, CHALF is more volatile compared to CCHWF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs AIHLF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, AIHLF has a market cap of 507.8M. Regarding current trading prices, CHALF is priced at $0.38, while AIHLF trades at $3.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas AIHLF's P/E ratio is 10.83. In terms of profitability, CHALF's ROE is +0.00%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, CHALF is more volatile compared to AIHLF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs PEXXF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, CHALF is priced at $0.38, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, CHALF's ROE is +0.00%, compared to PEXXF's ROE of N/A. Regarding short-term risk, CHALF is more volatile compared to PEXXF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs KHTRF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, KHTRF has a market cap of 423.4M. Regarding current trading prices, CHALF is priced at $0.38, while KHTRF trades at $4.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas KHTRF's P/E ratio is 60.71. In terms of profitability, CHALF's ROE is +0.00%, compared to KHTRF's ROE of +0.01%. Regarding short-term risk, CHALF is more volatile compared to KHTRF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs LRDSF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, LRDSF has a market cap of 375.6M. Regarding current trading prices, CHALF is priced at $0.38, while LRDSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas LRDSF's P/E ratio is -0.03. In terms of profitability, CHALF's ROE is +0.00%, compared to LRDSF's ROE of +1.61%. Regarding short-term risk, CHALF is more volatile compared to LRDSF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs CNGGF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, CNGGF has a market cap of 348.7M. Regarding current trading prices, CHALF is priced at $0.38, while CNGGF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas CNGGF's P/E ratio is -0.09. In terms of profitability, CHALF's ROE is +0.00%, compared to CNGGF's ROE of -1.60%. Regarding short-term risk, CHALF is more volatile compared to CNGGF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs GLASF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, GLASF has a market cap of 295.3M. Regarding current trading prices, CHALF is priced at $0.38, while GLASF trades at $5.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas GLASF's P/E ratio is -64.44. In terms of profitability, CHALF's ROE is +0.00%, compared to GLASF's ROE of +0.00%. Regarding short-term risk, CHALF is more volatile compared to GLASF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs BHCCF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, BHCCF has a market cap of 293.9M. Regarding current trading prices, CHALF is priced at $0.38, while BHCCF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas BHCCF's P/E ratio is -4.95. In terms of profitability, CHALF's ROE is +0.00%, compared to BHCCF's ROE of -0.18%. Regarding short-term risk, CHALF is more volatile compared to BHCCF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs PKBFF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, PKBFF has a market cap of 288.4M. Regarding current trading prices, CHALF is priced at $0.38, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas PKBFF's P/E ratio is -0.00. In terms of profitability, CHALF's ROE is +0.00%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, CHALF is more volatile compared to PKBFF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs BHHKF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, BHHKF has a market cap of 288.1M. Regarding current trading prices, CHALF is priced at $0.38, while BHHKF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas BHHKF's P/E ratio is -0.01. In terms of profitability, CHALF's ROE is +0.00%, compared to BHHKF's ROE of -1.94%. Regarding short-term risk, CHALF is more volatile compared to BHHKF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs PSIQ Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, PSIQ has a market cap of 232.4M. Regarding current trading prices, CHALF is priced at $0.38, while PSIQ trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas PSIQ's P/E ratio is N/A. In terms of profitability, CHALF's ROE is +0.00%, compared to PSIQ's ROE of -1.73%. Regarding short-term risk, CHALF and PSIQ have similar daily volatility (200.00).
CHALF vs VRNOF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, VRNOF has a market cap of 230.6M. Regarding current trading prices, CHALF is priced at $0.38, while VRNOF trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas VRNOF's P/E ratio is -0.65. In terms of profitability, CHALF's ROE is +0.00%, compared to VRNOF's ROE of -0.22%. Regarding short-term risk, CHALF is more volatile compared to VRNOF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs CPHRF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, CPHRF has a market cap of 230.1M. Regarding current trading prices, CHALF is priced at $0.38, while CPHRF trades at $8.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas CPHRF's P/E ratio is 24.94. In terms of profitability, CHALF's ROE is +0.00%, compared to CPHRF's ROE of +0.09%. Regarding short-term risk, CHALF is more volatile compared to CPHRF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs CRLBF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, CRLBF has a market cap of 205.7M. Regarding current trading prices, CHALF is priced at $0.38, while CRLBF trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas CRLBF's P/E ratio is -2.77. In terms of profitability, CHALF's ROE is +0.00%, compared to CRLBF's ROE of -0.16%. Regarding short-term risk, CHALF is more volatile compared to CRLBF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs PLNHF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, CHALF is priced at $0.38, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, CHALF's ROE is +0.00%, compared to PLNHF's ROE of -0.34%. Regarding short-term risk, CHALF is more volatile compared to PLNHF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs WLDFF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, WLDFF has a market cap of 170.2M. Regarding current trading prices, CHALF is priced at $0.38, while WLDFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas WLDFF's P/E ratio is N/A. In terms of profitability, CHALF's ROE is +0.00%, compared to WLDFF's ROE of -0.19%. Regarding short-term risk, CHALF is more volatile compared to WLDFF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs BKUH Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, BKUH has a market cap of 150.7M. Regarding current trading prices, CHALF is priced at $0.38, while BKUH trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas BKUH's P/E ratio is -50.00. In terms of profitability, CHALF's ROE is +0.00%, compared to BKUH's ROE of +0.10%. Regarding short-term risk, CHALF is more volatile compared to BKUH. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs HUMDF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, HUMDF has a market cap of 147.5M. Regarding current trading prices, CHALF is priced at $0.38, while HUMDF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas HUMDF's P/E ratio is -3.75. In terms of profitability, CHALF's ROE is +0.00%, compared to HUMDF's ROE of +8.06%. Regarding short-term risk, CHALF is more volatile compared to HUMDF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs COPHF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, CHALF is priced at $0.38, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas COPHF's P/E ratio is -0.02. In terms of profitability, CHALF's ROE is +0.00%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, CHALF is more volatile compared to COPHF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs PHCUF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, PHCUF has a market cap of 119.4M. Regarding current trading prices, CHALF is priced at $0.38, while PHCUF trades at $4.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas PHCUF's P/E ratio is 448.00. In terms of profitability, CHALF's ROE is +0.00%, compared to PHCUF's ROE of +0.00%. Regarding short-term risk, CHALF is more volatile compared to PHCUF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs LPCUF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, LPCUF has a market cap of 110.8M. Regarding current trading prices, CHALF is priced at $0.38, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas LPCUF's P/E ratio is 18.82. In terms of profitability, CHALF's ROE is +0.00%, compared to LPCUF's ROE of +0.05%. Regarding short-term risk, CHALF is more volatile compared to LPCUF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.
CHALF vs CNVCF Comparison
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 441.8B. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, CHALF is priced at $0.38, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of -4.75, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, CHALF's ROE is +0.00%, compared to CNVCF's ROE of +9.56%. Regarding short-term risk, CHALF is more volatile compared to CNVCF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.